Market Cap 125.10M
Revenue (ttm) 0.00
Net Income (ttm) -69.68M
EPS (ttm) N/A
PE Ratio 39.50
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,272,200
Avg Vol 1,462,816
Day's Range N/A - N/A
Shares Out 56.86M
Stochastic %K 81%
Beta 2.63
Analysts Strong Sell
Price Target $10.67

Latest News on BDTX

Black Diamond Therapeutics: In Decline, But Why?

Mar 13, 2025, 3:47 PM EDT - 2 months ago

Black Diamond Therapeutics: In Decline, But Why?


Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy

Oct 12, 2023, 8:31 AM EDT - 1 year ago

Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy


Black Diamond Therapeutics Announces CEO Transition

Sep 18, 2023, 7:00 AM EDT - 1 year ago

Black Diamond Therapeutics Announces CEO Transition